The urgent need for advanced childhood brain cancer research G34R-mutant pediatric diffuse glioma, a devastating brain cancer affecting children and young adults, poses significant challenges in treatment due to its aggressive nature, limited therapeutic options, and the long-term side effects. […]
This Pediatric Glioma has no known cure. Dr. Breunig is Taking on the Challenge. Read More »
Neuroblastoma is the most common extracranial solid tumor of childhood arising within the developing nervous system. Approximately half of neuroblastoma patients are diagnosed with high-risk disease, which is especially aggressive with a 50% survival rate. If a child’s high-risk neuroblastoma
Acute Myeloid leukemia (AML) is the second most common leukemia in children, and the prognosis after relapse is poor. Unlike current CAR T treatment for the most common childhood leukemia, acute lymphoblastic leukemia (ALL), patients with AML experience significant toxicity
Dr. Moghimi is developing next-generation CAR T-cells to treat pediatric AML. Read More »
As an infant, Lindsey Grubbs did what most babies do. She played, she napped, she cried, but she was dealing with something far from normal. “I was a baby, so of course I didn’t fully know what was happening
Clinical trial aims to bring new therapies to childhood brain tumors with low survival rates Bethesda, Md. – April 3, 2023 – CureSearch for Children’s Cancer, a national nonprofit on a mission to end childhood cancer by driving targeted and
CureSearch to fund Phase I clinical trial for pediatric brain cancer Read More »
“We were fortunate that CureSearch had just launched their Catapult Award program….It enabled researchers to access up to $2.5M in funding over three years, through a streamlined application process, rather than contending with multiple applications for smaller grants which would have lengthened
As we work to find new and less-toxic treatments for pediatric cancers, we know that smarter research funding is just one part of the solution. Long-term solutions require a seismic shift in the existing pediatric drug development process. This change
Updated 5/1/20 To the CureSearch Community: Like you, we’re closely monitoring the evolving situation surrounding COVID-19. With the safety of our patient families, volunteers and staff top of mind, all CureSearch-sponsored events through June 1st have been postponed, including our
COVID-19 Impact and Action Read More »
Mattel Children’s Foundation creates special doll to help children cope with hair loss Bethesda, MD – February 25, 2020 – Through a longstanding partnership with the Mattel Children’s Foundation, CureSearch for Children’s Cancer is proud to announce distribution of a new,
CureSearch to Distribute New Barbie Doll to Children Affected by Cancer Read More »
CureSearch IMPACT Series Forums bring global pediatric experts in academia and pharmaceutical companies together to accelerate the development of pediatric cancer drugs. “Children with cancer wait an average of 6.5 years longer than adults to access new drugs.”1 Cancer is
